Alzheimer's disease stories

Apr 14, 2026

Blood Test Predicts Alzheimer's Progression Years Before Symptoms or Brain Scan Changes

Mass General Brigham researchers found that plasma phosphorylated tau 217 (pTau217) blood test can predict progression of amyloid PET scans years before symptoms appear or brain imaging shows changes.

Apr 14, 2026·1 source

APOE4 Alzheimer's Gene Found to Weaken Bone Quality in Women

Scientists at the Buck Institute and UC San Francisco discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deterioration in women, revealing an unexpected connection between neurological and skeletal health.

Apr 14, 2026·1 source

Top claims

▪The plasma phosphorylated tau 217 blood test could make Alzheimer's disease prediction simpler than current brain imaging methods.
▪The plasma phosphorylated tau 217 blood test can detect Alzheimer's disease progression years before symptoms appear.
▪The Mass General Brigham study results on plasma phosphorylated tau 217 (pTau217) are published in Nature Communications.

Topics

Brain health & dementia researchers Brain longevity Biomarkers & bloodwork testing Biomarkers experts Age related cognitive decline Aging biology experts

Related entities

Mass General Brigham Neurology Women's health Genetic

Featured Stories

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

Aug 7, 2026·2 sources